Press Releases News Year None202020192018201720162015201420132012 Ophthotech Expands Innovative Retinal Disease Pipeline with Acquisition of Versant Ventures’ Inception 4 Oct 31, 2018 | Ophthotech Corporation to Report Third Quarter 2018 Financial Results and Host Conference Call on Wednesday, October 31, 2018 Oct 23, 2018 | Ophthotech Completes Patient Recruitment As Planned for its Phase 2b Clinical Trial of Zimura® Monotherapy for Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration Oct 04, 2018 | Ophthotech Corporation to Present at Chardan’s 2nd Annual Genetic Medicines Conference Oct 03, 2018 | Scientific Data for Novel Adeno-Associated Virus Gene Therapy in Rhodopsin-Mediated Autosomal Dominant Retinitis Pigmentosa Published in Proceedings of the National Academy of Sciences Aug 22, 2018 | Ophthotech Reports Second Quarter 2018 Financial and Operating Results Aug 01, 2018 | Ophthotech Corporation to Report Second Quarter 2018 Financial Results and Host Conference Call on Wednesday, August 1, 2018 Jul 25, 2018 | Ophthotech Enters into Gene Therapy Agreements with the University of Florida and the University of Pennsylvania Jun 07, 2018 | Ophthotech Reports First Quarter 2018 Financial and Operating Results May 09, 2018 | Ophthotech Completes Patient Recruitment in the Phase 2a Clinical Trial of Zimura® in Combination with Anti-VEGF Therapy in Wet Age-Related Macular Degeneration May 01, 2018 | Pagination First page « first Previous page ‹ previous Page 1 Page 2 Page 3 Page 4 Current page 5 Page 6 Page 7 Page 8 Page 9 … Next page next › Last page last »
Ophthotech Expands Innovative Retinal Disease Pipeline with Acquisition of Versant Ventures’ Inception 4 Oct 31, 2018 |
Ophthotech Corporation to Report Third Quarter 2018 Financial Results and Host Conference Call on Wednesday, October 31, 2018 Oct 23, 2018 |
Ophthotech Completes Patient Recruitment As Planned for its Phase 2b Clinical Trial of Zimura® Monotherapy for Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration Oct 04, 2018 |
Ophthotech Corporation to Present at Chardan’s 2nd Annual Genetic Medicines Conference Oct 03, 2018 |
Scientific Data for Novel Adeno-Associated Virus Gene Therapy in Rhodopsin-Mediated Autosomal Dominant Retinitis Pigmentosa Published in Proceedings of the National Academy of Sciences Aug 22, 2018 |
Ophthotech Corporation to Report Second Quarter 2018 Financial Results and Host Conference Call on Wednesday, August 1, 2018 Jul 25, 2018 |
Ophthotech Enters into Gene Therapy Agreements with the University of Florida and the University of Pennsylvania Jun 07, 2018 |
Ophthotech Completes Patient Recruitment in the Phase 2a Clinical Trial of Zimura® in Combination with Anti-VEGF Therapy in Wet Age-Related Macular Degeneration May 01, 2018 |
Press Releases News Year None202020192018201720162015201420132012 Ophthotech Expands Innovative Retinal Disease Pipeline with Acquisition of Versant Ventures’ Inception 4 Oct 31, 2018 | Ophthotech Corporation to Report Third Quarter 2018 Financial Results and Host Conference Call on Wednesday, October 31, 2018 Oct 23, 2018 | Ophthotech Completes Patient Recruitment As Planned for its Phase 2b Clinical Trial of Zimura® Monotherapy for Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration Oct 04, 2018 | Ophthotech Corporation to Present at Chardan’s 2nd Annual Genetic Medicines Conference Oct 03, 2018 | Scientific Data for Novel Adeno-Associated Virus Gene Therapy in Rhodopsin-Mediated Autosomal Dominant Retinitis Pigmentosa Published in Proceedings of the National Academy of Sciences Aug 22, 2018 | Ophthotech Reports Second Quarter 2018 Financial and Operating Results Aug 01, 2018 | Ophthotech Corporation to Report Second Quarter 2018 Financial Results and Host Conference Call on Wednesday, August 1, 2018 Jul 25, 2018 | Ophthotech Enters into Gene Therapy Agreements with the University of Florida and the University of Pennsylvania Jun 07, 2018 | Ophthotech Reports First Quarter 2018 Financial and Operating Results May 09, 2018 | Ophthotech Completes Patient Recruitment in the Phase 2a Clinical Trial of Zimura® in Combination with Anti-VEGF Therapy in Wet Age-Related Macular Degeneration May 01, 2018 | Pagination First page « first Previous page ‹ previous Page 1 Page 2 Page 3 Page 4 Current page 5 Page 6 Page 7 Page 8 Page 9 … Next page next › Last page last »
Ophthotech Expands Innovative Retinal Disease Pipeline with Acquisition of Versant Ventures’ Inception 4 Oct 31, 2018 |
Ophthotech Corporation to Report Third Quarter 2018 Financial Results and Host Conference Call on Wednesday, October 31, 2018 Oct 23, 2018 |
Ophthotech Completes Patient Recruitment As Planned for its Phase 2b Clinical Trial of Zimura® Monotherapy for Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration Oct 04, 2018 |
Ophthotech Corporation to Present at Chardan’s 2nd Annual Genetic Medicines Conference Oct 03, 2018 |
Scientific Data for Novel Adeno-Associated Virus Gene Therapy in Rhodopsin-Mediated Autosomal Dominant Retinitis Pigmentosa Published in Proceedings of the National Academy of Sciences Aug 22, 2018 |
Ophthotech Corporation to Report Second Quarter 2018 Financial Results and Host Conference Call on Wednesday, August 1, 2018 Jul 25, 2018 |
Ophthotech Enters into Gene Therapy Agreements with the University of Florida and the University of Pennsylvania Jun 07, 2018 |
Ophthotech Completes Patient Recruitment in the Phase 2a Clinical Trial of Zimura® in Combination with Anti-VEGF Therapy in Wet Age-Related Macular Degeneration May 01, 2018 |
